DARE BIOSCIENCE INC's ticker is DARE and the CUSIP is 23666P101. A total of 40 filers reported holding DARE BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,861 | -49.3% | 6,200 | 0.0% | 0.00% | – |
| Q2 2023 | $5,642 | -12.5% | 6,200 | 0.0% | 0.00% | – |
| Q1 2023 | $6,448 | -46.3% | 6,200 | -56.3% | 0.00% | – |
| Q4 2022 | $12,000 | -52.0% | 14,200 | -43.7% | 0.00% | – |
| Q3 2022 | $25,000 | -7.4% | 25,200 | +13.5% | 0.00% | – |
| Q2 2022 | $27,000 | -12.9% | 22,200 | +6.9% | 0.00% | – |
| Q1 2022 | $31,000 | -8.8% | 20,763 | +23.9% | 0.00% | – |
| Q4 2021 | $34,000 | +88.9% | 16,763 | +55.7% | 0.00% | – |
| Q3 2021 | $18,000 | +80.0% | 10,763 | +86.8% | 0.00% | – |
| Q2 2021 | $10,000 | +900.0% | 5,763 | +655.3% | 0.00% | – |
| Q1 2021 | $1,000 | -87.5% | 763 | -87.3% | 0.00% | – |
| Q4 2020 | $8,000 | +33.3% | 6,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 326,243 | $323,000 | 0.25% |
| INTERWEST VENTURE MANAGEMENT CO | 50,368 | $50,000 | 0.04% |
| FOUNDERS FINANCIAL SECURITIES LLC | 97,500 | $102,000 | 0.03% |
| Virtu Financial LLC | 41,320 | $41,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 13,420 | $13,000 | 0.00% |
| Renaissance Technologies | 652,084 | $645,000 | 0.00% |
| Edge Wealth Management LLC | 3,000 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 132 | $0 | 0.00% |
| NORTHERN TRUST CORP | 50,527 | $50,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |